Evans KG - Search Results

1

Vorinostat for the treatment of bullous pemphigoid in the setting of advanced, refractory cutaneous T-cell lymphoma.

Gardner JM, Evans KG, Goldstein S, Kim EJ, Vittorio CC, Rook AH. Gardner JM, et al. Among authors: evans kg. Arch Dermatol. 2009 Sep;145(9):985-8. doi: 10.1001/archdermatol.2009.229. Arch Dermatol. 2009. PMID: 19770436 No abstract available.

2

Increased programmed death-1 expression on CD4+ T cells in cutaneous T-cell lymphoma: implications for immune suppression.

Samimi S, Benoit B, Evans K, Wherry EJ, Showe L, Wysocka M, Rook AH. Samimi S, et al. Arch Dermatol. 2010 Dec;146(12):1382-8. doi: 10.1001/archdermatol.2010.200. Epub 2010 Aug 16. Arch Dermatol. 2010. PMID: 20713771 Free PMC article.

3

Romidepsin and interferon gamma: a novel combination for refractory cutaneous T-cell lymphoma.

Samimi S, Morrissey K, Anshelevich S, Evans K, Gardner J, Musiek A, Vittorio C, Rook A, Kim E. Samimi S, et al. J Am Acad Dermatol. 2013 Jan;68(1):e5-6. doi: 10.1016/j.jaad.2011.06.043. J Am Acad Dermatol. 2013. PMID: 23244387 No abstract available.

4

Update on treatment of cutaneous T-cell lymphoma.

Gardner JM, Evans KG, Musiek A, Rook AH, Kim EJ. Gardner JM, et al. Among authors: evans kg. Curr Opin Oncol. 2009 Mar;21(2):131-7. doi: 10.1097/CCO.0b013e3283253190. Curr Opin Oncol. 2009. PMID: 19532014 Review.

5

Immune modulators as therapeutic agents for cutaneous T-cell lymphoma.

Rook AH, Benoit B, Kim EJ, Vittorio CC, Anshelevich A, Raphael BA, Introcaso CE, Gardner JM, Evans KG, Morrissey K, Samimi S, Musiek AC, Showe LC, Wasik MA, Wysocka M. Rook AH, et al. Among authors: evans kg. Clin Lymphoma Myeloma Leuk. 2010 Sep;10 Suppl 2(0 2):S93-5. doi: 10.3816/CLML.2010.s.017. Clin Lymphoma Myeloma Leuk. 2010. PMID: 20826407 Free PMC article.

6

Validity assessment of the cutaneous T-cell lymphoma severity index to predict prognosis in advanced mycosis fungoides/Sézary syndrome.

Evans KG, Troxel AB, DeNardo BJ, Introcaso CE, Rook AH, Kim EJ. Evans KG, et al. J Am Acad Dermatol. 2011 Apr;64(4):682-9. doi: 10.1016/j.jaad.2009.01.044. Epub 2011 Feb 18. J Am Acad Dermatol. 2011. PMID: 21315479

7

High clinical response rate of Sezary syndrome to immunomodulatory therapies: prognostic markers of response.

Raphael BA, Shin DB, Suchin KR, Morrissey KA, Vittorio CC, Kim EJ, Gardner JM, Evans KG, Introcaso CE, Samimi SS, Gelfand JM, Rook AH. Raphael BA, et al. Among authors: evans kg. Arch Dermatol. 2011 Dec;147(12):1410-5. doi: 10.1001/archdermatol.2011.232. Epub 2011 Aug 15. Arch Dermatol. 2011. PMID: 21844430

8

Acute onset of leg nodules in a sporotrichoid pattern--quiz case. Diagnosis: primary cutaneous diffuse large B-cell lymphoma, leg type (PCLBCL-LT).

Evans KG, Abraham RM, Mihova D, Xu X, Frank DM, Rosenbach M, Kim EJ. Evans KG, et al. Arch Dermatol. 2012 Oct;148(10):1199-200. doi: 10.1001/archderm.148.10.1199-b. Arch Dermatol. 2012. PMID: 23069960 No abstract available.

9

Congestive heart failure in a patient with cutaneous T-cell lymphoma treated with low-dose interferon alfa-2b.

Evans KG, Loren AW, Rook AH, Kim EJ, Glassberg HL. Evans KG, et al. Arch Dermatol. 2011 Sep;147(9):1122-3. doi: 10.1001/archdermatol.2011.246. Arch Dermatol. 2011. PMID: 21931064 No abstract available.

10

Chronic acyclovir-resistant HSV-2 ulcer in an immunosuppressed patient treated with topical cidofovir.

Evans KG, Morrissey KA, Goldstein SC, Vittorio CC, Rook AH, Kim EJ. Evans KG, et al. Arch Dermatol. 2011 Dec;147(12):1462-3. doi: 10.1001/archderm.147.12.1462. Arch Dermatol. 2011. PMID: 22184781 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

55 results

Search Page

Filters